Menu
Back to Journals » International Journal of Nanomedicine » Volume 8 » Issue 1
Immunomagnetic nanoparticle-based assays for detection of biomarkers
Authors Park H, Hwang M, Lee KH
Received 22 July 2013
Accepted for publication 11 September 2013
Published 22 November 2013 Volume 2013:8(1) Pages 4543—4552
DOI https://doi.org/10.2147/IJN.S51893
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Hoyoung Park,1,2 Mintai P Hwang,1 Kwan Hyi Lee1,2
1Center for Biomaterials, Biomedical Research Institute, Korea Institute of Science and Technology, 2Department of Biomedical Engineering, University of Science and Technology, Seoul, Republic of Korea
Abstract: The emergence of biomarkers as key players in the paradigm shift towards preventative medicine underscores the need for their detection and quantification. Advances made in the field of nanotechnology have played a crucial role in achieving these needs, and have contributed to recent advances in the field of medicine. Nanoparticle-based immunomagnetic assays, in particular, offer numerous advantages that utilize the unique physical properties of magnetic nanoparticles. In this review, we focus on recent developments and trends with regards to immunomagnetic assays used for detection of biomarkers. The various immunomagnetic assays are categorized into the following: particle-based multiplexing, signal control, microfluidics, microarray, and automation. Herein, we analyze each category and discuss their advantages and disadvantages.
Keywords: magnetic, multiplex, signal control, microfluidics, microarrays, automation
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.